The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs DOI Creative Commons

David Frisvold,

Meeshanthini V. Dogan,

Timur Dogan

et al.

Advances in Therapy, Journal Year: 2024, Volume and Issue: 41(6), P. 2367 - 2380

Published: April 25, 2024

The cost of secondary prevention coronary heart disease (CHD) is continuing to increase, with a substantial portion this acceleration being driven by the expense confirmatory diagnostic testing. Conceivably, newly developed precision epigenetic technologies could drive down these costs. However, at current time, their impact on overall for CHD care poorly understood. We hypothesized that use developed, highly sensitive, and specific test, PrecisionCHD, decrease costs prevention.

Language: Английский

Decoding the year of 2023: welcome to the 16th Volume of Epigenomics DOI

Man‐Hong Leung

Epigenomics, Journal Year: 2023, Volume and Issue: 16(1), P. 1 - 4

Published: Nov. 27, 2023

Language: Английский

Citations

1
The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs DOI Creative Commons

David Frisvold,

Meeshanthini V. Dogan,

Timur Dogan

et al.

Advances in Therapy, Journal Year: 2024, Volume and Issue: 41(6), P. 2367 - 2380

Published: April 25, 2024

The cost of secondary prevention coronary heart disease (CHD) is continuing to increase, with a substantial portion this acceleration being driven by the expense confirmatory diagnostic testing. Conceivably, newly developed precision epigenetic technologies could drive down these costs. However, at current time, their impact on overall for CHD care poorly understood. We hypothesized that use developed, highly sensitive, and specific test, PrecisionCHD, decrease costs prevention.

Language: Английский

Citations

0